University of Colorado, Denver
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Colorado, Denver sits in the top decile of US sponsors by registered trial count (#21 of 15,742 sponsors by registered trial count).
University of Colorado, Denver: 1,283 sponsored US clinical trials, 265 recruiting.
University of Colorado, Denver sponsors 1,283 registered US clinical trials on ClinicalTrials.gov, 265 of them currently recruiting, and 830 completed. 121 of these trials are in Phase 3-4 (later-stage) and 245 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 23 trials.
Top-decile sponsor footprint
University of Colorado, Denver ranks in the top decile of sponsors by registered trial count (#21 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
830 of 908 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,283 total, page 15 of 26
Prevention of Enamel Demineralization by Use of K18-smooth Surface Sealant
NCT03306433
Effects of Hip Distraction Without a Perineal Post on Venous Blood Flow and Peripheral Nerve Conduction
NCT03417934
Pilot Study of Targeted Normoxia in Critically Ill Trauma Patients
NCT03789396
Intermittent Fasting Versus Daily Caloric Restriction for Weight Loss
NCT03411356
Arsenic Trioxide With Cyclophosphamide in Patients With Relapsed/Refractory Acute Myeloid Leukemia
NCT03318016
Evaluating Crizotinib in the Neoadjuvant Setting in Patients With Non-small Cell Lung Cancer
NCT03088930
WatchPAT Device Validation Study Compared to Polysomnography
NCT03188718
CNS Study of Patients Switching From Tacrolimus to Envarsus
NCT03270462
Tucatinib, Palbociclib and Letrozole in Metastatic Hormone Receptor Positive and HER2-positive Breast Cancer
NCT03054363
Personalized Experiences to Inform Improved Communication for Minorities With Life Limiting Illness
NCT03391115
TESTO: Testosterone Effects on Short-Term Outcomes in Infants With XXY
NCT03325647
Home Telemedicine to Optimize Health Outcomes in High-Risk Youth With Type 1 Diabetes
NCT03324438
Pembrolizumab and All-Trans Retinoic Acid Combination Treatment of Advanced Melanoma
NCT03200847
Early Feeding Following Percutaneous Gastrostomy Tube Placement
NCT03319576
Transcranial Electrical Stimulation for Cervical Dystonia
NCT03369613
Stereotactic Body Radiation Therapy in Treating Patients With Recurrent Primary Ovarian or Uterine Cancer
NCT03325634
Motivational Interviewing in Palliative Care
NCT03332615
Haploidentical CD34+ Selected Cells Combined With Single Unit Umbilical Cord Blood Transplant for Treatment of High-risk Hematologic Disorders
NCT03093844
Reducing Urinary Tract Infection Rates Using a Controlled Aseptic Protocol for Catheter Insertion
NCT03101371
InterventiOn of Biventricular Pacemaker Function on ventrIcular Function Among Patients With LVAD's
NCT03232736
Study Comparing Prandial Insulin Aspart vs. Technosphere Insulin in Patients With Type 1 Diabetes on Multiple Daily Injections: Investigator-Initiated A Real-life Pilot Study-STAT Study
NCT03143816
Study of Pembrolizumab and Cabozantinib in Patients With Metastatic Renal Cell Carcinoma
NCT03149822
SunSmart Intervention in Schools
NCT03745872
Mother's Milk Messaging: Evaluation of a Bilingual Application (APP) to Support Initiation and Exclusive Breastfeeding in New Mothers
NCT02958475
Adolescent Self-Care and Knowledge Education in Diabetes--Improved by Texting
NCT03241212
Use of Device Data to Predict Frailty in Individuals
NCT03079726
Effect of Acid Blockade on Microbiota and Inflammation in Cystic Fibrosis (CF)
NCT02769637
Centralized IIS-based Reminder/Recall to Increase Childhood Influenza Vaccination Rates_2nd Trial in Colorado
NCT03246100
Design of a Dressing for Gastrostomy Buttons in Pediatric Population
NCT03142750
Fit After Baby: Increasing Postpartum Weight Loss in Women at Increased Risk for Cardiometabolic Disease
NCT03215173
ENgaging in Advance Care Planning Talks Group Visit Intervention
NCT03141242
Registry of Preterm Newborns With Severe Pulmonary Hypertension
NCT03310346
Bright by Three (BB3) Effectiveness Study
NCT02717390
Helping Moms to be Healthy After Baby
NCT03257657
Early Glargine (Lantus) in DKA Management in Children With Type 1 Diabetes
NCT03107208
Effects of Progressive Intensity Exercise Training on Glycemic Control in Older Adults
NCT03154073
On-Q Catheter Caregiver Education
NCT03372889
The Good Tastes Study: Young Children's Food Acceptance Patterns
NCT04549233
Fulvestrant Plus Enzalutamide in ER+/Her2- Advanced Breast Cancer
NCT02953860
Stimulation of the Rostral Zona Incerta for Parkinson's Disease
NCT03212885
Cardiac Rehabilitation and Sedentary Behavior
NCT03200756
Role of Acute Exercise Modality on Appetite Regulation and Energy Intake
NCT03143868
Choline Supplementation During Pregnancy: Impact on Attention and Social Withdrawal
NCT03028857
Apoyo Con Carino: Patient Navigation for Palliative Care for Non-Cancer Illness
NCT03181750
Improving Our Understanding of Suicidal Ideation in Cancer Survivors
NCT04866758
Diabetic Kidney Alarm (DKA) Study
NCT03128229
Cannabis Versus Oxycodone for Pain Relief
NCT02892591
Implementation of Transdx Group for POTS
NCT03185247
Health, Fitness, and Quality of Life in Adolescent Girls With Turner Syndrome
NCT03181230
Static Progressive Splinting in the Management of Knee Stiffness Following Total Knee Arthroplasty
NCT04837872
What is open in the University of Colorado, Denver pipeline
265 recruiting of 1,283 indexed (21% open); 830 completed (65%).
Phase mix: 121 late (III/IV) vs 245 early (I/II) (early-phase heavy).
Top condition: Obesity (23 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Colorado, Denver: open-pipeline peers nationwide
Peers matched on 1,283 registered trials and 21% open enrollment, not the therapeutic-area sidebar.
University of Colorado, Denver sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,283 trials (± recruiting share)
- AstraZeneca · 1,285 trials · 12% recruiting
- University of Michigan · 1,327 trials · 13% recruiting
- University of Pittsburgh · 1,238 trials · 13% recruiting
- Eli Lilly and Company · 1,341 trials · 9% recruiting
Sponsors near 21% open enrollment (± trial volume)
- Cedars-Sinai Medical Center · 21% recruiting · 339 trials
- Craig Hospital · 21% recruiting · 29 trials
- W.L.Gore & Associates · 21% recruiting · 53 trials
- Georgia Institute of Technology · 21% recruiting · 24 trials
Related
What to do with this University of Colorado, Denver page
1,283 registered trials is a research-attention snapshot, not an endorsement of University of Colorado, Denver or any single study.
- 265 of University of Colorado, Denver's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition University of Colorado, Denver studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Colorado, Denver pipeline card: 1,283 registered trials from official public datasets.Report a data error.